ALPINE IMMUNE SCIENCES, INC.

Profile

Company Names

ALPINE IMMUNE SCIENCES, INC.
N30 PHARMACEUTICALS, INC.

Addresses

188 EAST BLAINE ST., SUITE 200, SEATTLE, WA 98102

201 ELLIOTT AVE. WEST, SUITE 230, SEATTLE, WA 98119

3122 STERLING CIRCLE, SUITE 200, BOULDER, CO 80301

Phone Numbers

206-788-4545
720-945-7700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$206,274,926.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-09-17 
$90,999,934.00 
$91,003,125.00 
$3,191.00 
Equity 
3
2020-07-28 
$60,000,013.00 
$82,666,486.00 
$22,666,473.00 
Equity 
2
2019-01-18 
$25,274,979.00 
$48,660,651.00 
$23,385,672.00 
Equity 
1
2014-11-18 
$30,000,000.00 
$40,000,000.00 
$10,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
CONWAY 
DIRECTOR
CLINONE, INC.   |  ALPINE IMMUNE SCIENCES, INC.
HOWARD 
 
FURST 
DIRECTOR
ZENGO FITNESS LLC   |  N30 PHARMACEUTICALS, INC.   |  APPELLO PHARMACEUTICALS, INC.
MITCHELL 
 
GOLD 
EXECUTIVE OFFICER, DIRECTOR
ALPINE IMMUNE SCIENCES, INC.
ZELANNA 
 
GOLDBERG 
EXECUTIVE OFFICER
ALPINE IMMUNE SCIENCES, INC.
NATASHA 
 
HERNDAY 
DIRECTOR
ALPINE IMMUNE SCIENCES, INC.
JONATHAN 
 
LEFF 
DIRECTOR
HANA BIOSCIENCES INC   |  RIB X PHARMACEUTICALS INC   |  TALON THERAPEUTICS, INC.   |  N30 PHARMACEUTICALS, INC.   |  AUDENTES THERAPEUTICS, INC.   |  AVEXIS, INC.   |  APRECIA PHARMACEUTICALS CO   |  PROTEON THERAPEUTICS INC   |  DRACEN PHARMACEUTICALS, INC.   |  ARS PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  CHONDRIAL THERAPEUTICS HOLDINGS, LLC   |  LARIMAR THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AEROVATE THERAPEUTICS, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  INNERVACE, INC.   |  BIOMX INC.   |  ELION THERAPEUTICS, INC.   |  AXONIS THERAPEUTICS, INC.
MARK 
JAMES 
LITTON 
EXECUTIVE OFFICER
ALDER BIOPHARMACEUTICALS INC   |  ALPINE IMMUNE SCIENCES, INC.
EVAN 
 
LOH 
DIRECTOR
PARATEK PHARMACEUTICALS INC   |  N30 PHARMACEUTICALS, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.
JOSEPH 
 
LOSCALZO 
DIRECTOR
N30 PHARMACEUTICALS, INC.   |  LEAP THERAPEUTICS, INC.   |  SCIPHER MEDICINE CORP
JOHN 
 
MOORE 
DIRECTOR
HARPSWELL CAPITAL PARTNERS LP   |  QUINTILES TRANSNATIONAL HOLDINGS INC.   |  HARPSWELL CAPITAL OFFSHORE FUND, LTD   |  LIFESHARE TECHNOLOGIES, LLC   |  USEED, INC.   |  WASH CYCLE LAUNDRY INC.   |  GELATO FIASCO, INC.   |  N30 PHARMACEUTICALS, INC.   |  MARSHALL VENTURES FUND 1, LLC   |  MILKCRATE, LLC   |  WYZERR, INC.   |  ARIEL PRECISION MEDICINE, LLC   |  KALYX DEVELOPMENT INC.   |  TWINE HEALTH, INC.   |  LOPEZ ISLAND BREWING CO   |  TEARSOLUTIONS, INC.   |  LIBERATE MEDICAL, INC.   |  SCIENTIFIC INDUSTRIES INC   |  GRYPHON ENVIRONMENTAL LLC   |  TRETE INC.   |  AMERICO BANCSHARES, INC.
CHRISTOPHER 
 
PEETZ 
DIRECTOR
ALPINE IMMUNE SCIENCES, INC.   |  MIRUM PHARMACEUTICALS, INC.
STANFORD 
 
PENG 
EXECUTIVE OFFICER
ALPINE IMMUNE SCIENCES, INC.
JAMES 
PAUL 
RICKEY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.   |  SOUND PHARMACEUTICALS INC   |  ALPINE IMMUNE SCIENCES, INC.
PAUL 
 
SEKHRI 
DIRECTOR
ARYX THERAPEUTICS, INC.   |  MACROGENICS INC   |  PATIENTSAFE SOLUTIONS, INC.   |  TANDEM DIABETES CARE INC   |  LYCERA CORP   |  PETRA PHARMA CORP   |  LIKEMINDS, INC./DE   |  COMPUGEN LTD   |  ALPINE IMMUNE SCIENCES, INC.   |  EGENESIS, INC.   |  ADITUM BIO FUND 1, L.P.   |  BIOMX INC.   |  AXCELLA HEALTH INC.
TOM 
 
SOKOLOWSKI 
EXECUTIVE OFFICER
N30 PHARMACEUTICALS, INC.
PETER 
 
THOMPSON 
DIRECTOR
TRUBION PHARMACEUTICALS, INC   |  RESPONSE BIOMEDICAL CORP   |  TV ONE LLC   |  TV ONE CAPITAL CORP.   |  CODA THERAPEUTICS INC   |  METHYLGENE INC.   |  CARDIOXYL PHARMACEUTICALS INC   |  PRONAI THERAPEUTICS INC   |  EQDERIVATIVES, INC.   |  ADAPTIMMUNE LTD   |  CORVUS PHARMACEUTICALS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  E-SCAPE BIO, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  CLEAVE BIOSCIENCES, INC.   |  PMV PHARMACEUTICALS, INC.   |  PREVAIL THERAPEUTICS INC.   |  SYNTHORX, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  EDGEWISE THERAPEUTICS, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  ESCAPE BIO, INC.   |  CRANIOVATION, INC.   |  SPARROW PHARMACEUTICALS, INC.   |  ALPHEUS MEDICAL, INC.   |  GENNAO BIO, INC.   |  TERREMOTO BIOSCIENCES, INC.
JAMES 
 
TOPPER 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  INCLINE THERAPEUTICS, INC.   |  PORTOLA PHARMACEUTICALS INC   |  ATTEROCOR, INC.   |  SEMNUR PHARMACEUTICALS, INC.   |  PRONAI THERAPEUTICS INC   |  ALLENA PHARMACEUTICALS, INC.   |  CHANRX CORP.   |  ANAPTYSBIO INC   |  LAGUNA PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  MERGANSER BIOTECH, INC.   |  ALCRESTA, INC.   |  ALCRESTA THERAPEUTICS, INC.   |  MILLENDO THERAPEUTICS, INC.   |  APTINYX INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  ENLAZA THERAPEUTICS, INC.
JAY 
 
VENKATESAN 
DIRECTOR
LION BIOTECHNOLOGIES, INC.   |  AURASENSE THERAPEUTICS, LLC   |  ONCOTHYREON INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  TRANSPLANT GENOMICS INC.   |  ANGION BIOMEDICA CORP.   |  TIVORSAN PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  ELICIO THERAPEUTICS, INC.
CUI 
 
XIANGMIN 
DIRECTOR
GENAPSYS, INC.   |  ALPINE IMMUNE SCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-09-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-09-17 
2020-08-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-28 
2019-01-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-01-18 
2014-11-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
COWEN AND COMPANY
7616
NONE
NONE
OPPENHEIMER + CO. INC.
249
NONE
NONE
PIPER JAFFRAY + CO.
665